1. Home
  2. VRNA vs EMN Comparison

VRNA vs EMN Comparison

Compare VRNA & EMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRNA
  • EMN
  • Stock Information
  • Founded
  • VRNA 2005
  • EMN 1920
  • Country
  • VRNA United Kingdom
  • EMN United States
  • Employees
  • VRNA N/A
  • EMN N/A
  • Industry
  • VRNA Biotechnology: Pharmaceutical Preparations
  • EMN Major Chemicals
  • Sector
  • VRNA Health Care
  • EMN Industrials
  • Exchange
  • VRNA Nasdaq
  • EMN Nasdaq
  • Market Cap
  • VRNA 8.3B
  • EMN 9.2B
  • IPO Year
  • VRNA 2017
  • EMN 1993
  • Fundamental
  • Price
  • VRNA $105.18
  • EMN $58.78
  • Analyst Decision
  • VRNA Buy
  • EMN Buy
  • Analyst Count
  • VRNA 11
  • EMN 14
  • Target Price
  • VRNA $114.10
  • EMN $95.93
  • AVG Volume (30 Days)
  • VRNA 8.1M
  • EMN 1.7M
  • Earning Date
  • VRNA 08-11-2025
  • EMN 07-31-2025
  • Dividend Yield
  • VRNA N/A
  • EMN 5.65%
  • EPS Growth
  • VRNA N/A
  • EMN N/A
  • EPS
  • VRNA N/A
  • EMN 7.12
  • Revenue
  • VRNA $118,535,000.00
  • EMN $9,286,000,000.00
  • Revenue This Year
  • VRNA $893.95
  • EMN N/A
  • Revenue Next Year
  • VRNA $73.76
  • EMN $3.24
  • P/E Ratio
  • VRNA N/A
  • EMN $8.26
  • Revenue Growth
  • VRNA N/A
  • EMN 1.52
  • 52 Week Low
  • VRNA $18.51
  • EMN $56.83
  • 52 Week High
  • VRNA $105.50
  • EMN $114.50
  • Technical
  • Relative Strength Index (RSI)
  • VRNA 70.25
  • EMN 18.59
  • Support Level
  • VRNA $104.58
  • EMN $76.63
  • Resistance Level
  • VRNA $105.31
  • EMN $78.53
  • Average True Range (ATR)
  • VRNA 0.22
  • EMN 2.10
  • MACD
  • VRNA -0.64
  • EMN -1.55
  • Stochastic Oscillator
  • VRNA 60.49
  • EMN 8.40

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

About EMN Eastman Chemical Company

Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.

Share on Social Networks: